Cue Biopharma Ownership | Who Owns Cue Biopharma?

Overview Forecast RevenueFinancials Chart

Cue Biopharma Ownership Summary

Cue Biopharma is owned by 18.88% institutional investors, 0.75% insiders, and 80.37% retail investors. Bleichroeder lp is the largest institutional shareholder, holding 7.14% of CUE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.18% of its assets in Cue Biopharma shares.

CUE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cue Biopharma	18.88%	0.75%	80.37%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bleichroeder lp	6.82M	7.14%	$4.90M
Catalytic wealth ria	4.63M	4.59%	$1.41M
Vanguard group	3.01M	2.99%	$919.28K
Blackrock	756.74K	1.53%	$938.35K
Geode capital management	803.29K	0.80%	$245.36K
Boothbay fund management	610.96K	0.64%	$439.10K
Bank of america corp /de/	242.57K	0.49%	$300.78K
Robertson stephens wealth management	478.50K	0.47%	$146.13K
Blackrock funding, inc. /de	449.16K	0.45%	$137.17K
Texas capital bank wealth management services	440.67K	0.44%	$134.58K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bleichroeder lp	6.82M	0.96%	$4.90M
Catalytic wealth ria	4.63M	0.05%	$1.41M
Advisory research	257.23K	0.02%	$184.87K
Texas capital bank wealth management services	440.67K	0.01%	$134.58K
Boothbay fund management	610.96K	0.01%	$439.10K
Angeles wealth management	120.00K	0.01%	$86.24K
Two sigma securities	39.51K	0.00%	$28.40K
Robertson stephens wealth management	478.50K	0.00%	$146.13K
Prevail innovative wealth advisors	18.99K	0.00%	$5.80K
Chicago partners investment group	85.94K	0.00%	$32.66K

Top Buyers

Holder	Shares	% Assets	Change
Catalytic wealth ria	4.63M	0.05%	1.20M
Boothbay fund management	610.96K	0.01%	610.96K
Texas capital bank wealth management services	440.67K	0.01%	407.57K
Jane street group	69.79K	-	69.79K
Stifel financial	246.56K	0.00%	50.00K

Top Sellers

Holder	Shares	% Assets	Change
Slate path capital lp	-	-	-2.40M
Blackrock	756.74K	-	-1.49M
Good life advisors	-	-	-400.00K
Monaco asset management sam	-	-	-253.19K
Y-intercept (hong kong)	-	-	-153.63K

New Positions

Holder	Shares	% Assets	Change	Value
Boothbay fund management	610.96K	0.01%	610.96K	$439.10K
Jane street group	69.79K	-	69.79K	$21.32K
Hightower advisors	10.93K	-	10.93K	$3.34K
New millennium group	5.75K	0.00%	5.75K	$1.76K
Macquarie group	1.80K	-	1.80K	$2.24K

Sold Out

Holder	Change
Sbi securities	-1.00
Assetmark	-2.00
Nelson, van denburg & campbell wealth management group	-7.00
Farther finance advisors	-43.00
Innealta capital	-49.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	43	-17.31%	19,047,417	5.47%	18	5.28%	13	-13.33%	10	-23.08%
Sep 30, 2025	49	8.89%	18,058,423	4.34%	18	5.75%	14	-17.65%	13	44.44%
Jun 30, 2025	46	-9.80%	17,348,745	52.15%	18	7.71%	18	12.50%	9	-30.77%
Mar 31, 2025	51	-10.53%	11,402,706	-3.03%	15	2.91%	16	-48.39%	13	116.67%
Dec 31, 2024	55	5.77%	11,733,877	-15.65%	22	3.11%	30	150.00%	6	-64.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.35M	2.18%	-1.00
Vanguard Total Stock Mkt Idx Inv	1.52M	1.67%	-
Vanguard Institutional Extnd Mkt Idx Tr	937.43K	1.03%	-
Fidelity Extended Market Index	388.19K	0.43%	-748.00
NT R2000 Growth Index Fund - NL	103.76K	0.17%	-
BlackRock Extended Equity Market K	103.23K	0.17%	-44.00
Fidelity Total Market Index	139.86K	0.15%	-
NT R2000 Index Fund - NL	89.94K	0.15%	-9.65K
iShares Micro-Cap ETF	99.35K	0.13%	-
Northern Trust Russell 2000 Growth Index	78.95K	0.13%	8.49K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 30, 2025	Sarraf Pasha	-	Buy	$23.17K
Dec 30, 2025	Sarraf Pasha	-	Buy	$27.60K
Dec 30, 2025	Sarraf Pasha	-	Buy	$24.33K
Dec 30, 2025	Sarraf Pasha	-	Buy	$23.35K
Dec 30, 2025	Sarraf Pasha	-	Buy	$1.31K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	1	-

CUE Ownership FAQ

Who Owns Cue Biopharma?

Cue Biopharma shareholders are primarily institutional investors at 18.88%, followed by 0.75% insiders and 80.37% retail investors. The average institutional ownership in Cue Biopharma's industry, Biotech Stocks , is 381.47%, which Cue Biopharma falls below.

Who owns the most shares of Cue Biopharma?

Cue Biopharma’s largest shareholders are Bleichroeder lp (6.82M shares, 7.14%), Catalytic wealth ria (4.63M shares, 4.59%), and Vanguard group (3.01M shares, 2.99%). Together, they hold 14.72% of Cue Biopharma’s total shares outstanding.

Does Blackrock own Cue Biopharma?

Yes, BlackRock owns 1.53% of Cue Biopharma, totaling 756.74K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 938.35K$. In the last quarter, BlackRock decreased its holdings by -1.487M shares, a -66.28% change.

Who is Cue Biopharma’s biggest shareholder by percentage of total assets invested?

Bleichroeder lp is Cue Biopharma’s biggest shareholder by percentage of total assets invested, with 0.96% of its assets in 6.82M Cue Biopharma shares, valued at 4.9M$.

Who is the top mutual fund holder of Cue Biopharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cue Biopharma shares, with 2.18% of its total shares outstanding invested in 1.35M Cue Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools